Skip to main content

Sportstech Brands Holding GmbH Provides Update on Discussions with Interactive Strength, Inc. (Nasdaq: TRNR)

BERLIN, Dec. 30, 2025 (GLOBE NEWSWIRE) — Sportstech Brands Holding GmbH (“Sportstech”) refers to discussions with Interactive Strength, Inc. (Nasdaq: TRNR), which have been ongoing since the end of 2024 regarding a potential acquisition of Sportstech. As part of these discussions, the parties have so far been unable to agree on key economic and strategic terms. Against this background, the negotiations have been suspended effective November 27, 2025, and at present, there is no mutually agreed basis to advance the process toward a binding agreement. Currently, no further discussions are taking place. The planned market entry of Sportstech into the U.S. market was an integral part of the strategic considerations in connection with the proposed acquisition. Due to the termination of the discussions, this objective cannot be achieved...

Continue reading

Applied Digital to Spin Out Cloud Business, Proposes Business Combination with EKSO to Launch ChronoScale

Proposed Business Combination with Nasdaq-listed EKSO to Form an Accelerated Focused GPU Platform Purpose Built for Next-Generation AI Workloads DALLAS, Dec. 29, 2025 (GLOBE NEWSWIRE) — Applied Digital (NASDAQ: APLD), a designer, builder, and operator of high-performance, sustainably engineered data centers and colocation services for artificial intelligence, cloud, networking and blockchain workloads, and EKSO Bionics Holdings, Inc. (Nasdaq: EKSO) (“EKSO”) announced today that Applied Digital and EKSO entered into a non-binding term sheet for a proposed business combination of Applied Digital’s cloud computing business, Applied Digital Cloud, with EKSO, which, once closed, will go forward as ChronoScale Corporation, an accelerated compute platform purpose-built to support artificial intelligence (“AI”) workloads (the “Proposed...

Continue reading

Royalty Pharma Acquires Remaining Royalty Interest in Roche’s Evrysdi for $240 Million and Potential Milestones

Royalty Pharma will now own 100% of the 8% to 16% Evrysdi royalty following multiple transactions with PTC since 2020 NEW YORK, Dec. 29, 2025 (GLOBE NEWSWIRE) — Royalty Pharma plc (Nasdaq: RPRX) today announced that it has acquired the final portion of PTC Therapeutics’ remaining royalty on Roche’s Evrysdi for $240 million upfront and up to $60 million in sales-based milestones. Evrysdi, marketed by Roche, is an orally administered survival motor neuron-2 (SMN2) splicing modifier for the treatment of spinal muscular atrophy. Evrysdi was approved by the FDA in 2020 and has treated over 21,000 patients worldwide. In 2024, Evrysdi generated sales of approximately CHF 1.6 billion ($1.9 billion), representing 18% year-over-year growth at constant exchange rates, and is projected to reach CHF 2.3 billion ($2.9 billion) of sales by 2030...

Continue reading

Quadvest Fair Market Value Determination Received; On Track for Mid-2026 Close

SAN JOSE, Calif., Dec. 29, 2025 (GLOBE NEWSWIRE) — H2O America (NASDAQ: HTO) today announced that its regulated Texas water and wastewater utility, The Texas Water Company (TWC), received the appraised fair market values (FMV) from the three Public Utility Commission of Texas (PUCT)-appointed appraisers for the assets of Quadvest LP, a regulated investor-owned water and wastewater utility operating in the Houston metro area. In accordance with Texas’ FMV statute, the purchase price of $483.6 million will serve as the ratemaking rate base. “We appreciate the hard work of all parties involved during the appraisal process,” said Aundrea Williams, President of TWC. “We believe the FMV determination supports our previously communicated benefits of the transaction.” TWC plans to file the Sale-Transfer-Merger (STM) application with the...

Continue reading

Nutriband Inc. Signs Agreement to Sell Majority Stake of Subsidiary Pocono Pharmaceutical for $5M USD to EarthVision Bio

Earthvision Bio, is currently developing and commercializing its line of sustainable products developed by Dr. Gordon Moore, the founder of Intel, and Dr. Hans Franke, ex-chairman for Chevron Europe Nutriband Inc. Shareholders will retain 10% of the shareholding in Earth Vision Bio following the acquisition The expected closing date for the transaction is Dec 31, 2025. ORLANDO, Fla., Dec. 29, 2025 (GLOBE NEWSWIRE) — Nutriband Inc. (NASDAQ: NTRB) (NASDAQ: NTRBW), today announced that it has signed an agreement to sell a 90% interest in its subsidiary Pocono Pharmaceutical for $5M USD to EarthVision Bio. Earthvision Bio has developed and are commercializing a new category of sustainable products created by Dr. Gordon Moore, the founder of Intel (NASDAQ: INTC), and Dr. Hans Franke, who was board chairman for Chevron Europe. The Company...

Continue reading

Verisk Ends Effort to Acquire AccuLynx

Executes Plan to Redeem Acquisition-Related Debt JERSEY CITY, N.J., Dec. 29, 2025 (GLOBE NEWSWIRE) — Verisk (Nasdaq: VRSK), a leading global data analytics and technology provider, announced today that it has terminated its definitive agreement to purchase AccuLynx. This decision follows the notification by the Federal Trade Commission (FTC) that it has not completed its review of the transaction by the December 26, 2025 termination date set forth in the agreement. The Company also announced that it will redeem the $1.50 billion aggregate principal amount of senior notes that were issued in connection with the planned acquisition for a price equal to 101% of their principal amount plus accrued and unpaid interest to the redemption date. The redemption is required pursuant to a special mandatory redemption provision in the terms...

Continue reading

VCI Global Signs Binding Term Sheet to Acquire Controlling 51% Stake in RTCAR Mexico, Secures Tier-1 Production Hub for Global Automotive Giant’s North American Expansion

Existing MOU with Global Automotive Giant Serves as Guaranteed Offtaker for EV and Hybrid Production; First Vehicle Delivery Expected in Q4 2026 KUALA LUMPUR, Malaysia, Dec. 29, 2025 (GLOBE NEWSWIRE) — VCI Global Limited (NASDAQ: VCIG) (“VCI Global” or the “Company”) today announced that it has entered a legally binding term sheet to acquire a 51% controlling equity interest in RTCAR Comercializadora de Suministros Automotrices, S.A. de C.V. (“RTCAR Mexico”), a premier Mexico-based automotive assembly and manufacturing platform. The acquisition provides VCI Global with an immediately operational, scalable industrial base to support high-volume production for a leading global automotive original equipment manufacturer (OEM) expanding its footprint in North America. Experienced Automotive Leadership and USMCA-Ready Operations RTCAR...

Continue reading

Wereldhave sells Sterrenburg in Dordrecht, successfully completes Ville2 acquisition and secures new long-term financing

Wereldhave announces the sale of Full Service Center Sterrenburg in Dordrecht (The Netherlands), the successful completion of the acquisition of Ville2 in Charleroi (Belgium) and new long-term financing for Wereldhave Belgium. These transactions, plus related valuation synergies, further strengthen Wereldhave’s balance sheet. Disposal of Sterrenburg in DordrechtFull Service Center Sterrenburg in Dordrecht has been sold to a fund managed by Pertinea, an independent Belgian real estate investment services firm. Gross proceeds from the transaction amount to € 60 million, excluding transfer tax, reflecting the book value of the asset. Transfer of the asset took place on 24 December 2025. The sale of Sterrenburg marks the completion of Wereldhave’s planned disposal program in the Netherlands. Successful completion of Ville2 acquisitionIn addition,...

Continue reading

Atos Group has signed a binding agreement to sell its Atos operations in South America to the Brazilian company Semantix

Press Release Atos Group has signed a binding agreement to sell its Atos operations in South America to the Brazilian company Semantix With this transaction the Atos Group accelerates the delivery of its Genesis Transformation plan. Paris, France – December 26, 2025 – Atos Group, a global leader of AI-powered digital transformation, today announces that it has signed a binding agreement for the sale of its South American operations to the Brazilian company Semantix. The perimeter sold currently employs circa 2,800 professionals across Brazil, Argentina, Chile, Colombia, Uruguay and Peru. This divestment is part of the ‘Genesis’ transformation plan, aimed at returning Atos Group to sustainable growth and improved profitability by re-focusing on core geographies and assets such as AI, cloud-enabled, secure solutions and services. The acquisition,...

Continue reading

Nexa Cards Enters Acquisition Discussions with OX Agency to Enhance AI-Based Identity and Security Capabilities

LONDON, Dec. 25, 2025 (GLOBE NEWSWIRE) — Nexa Cards, a global fintech company providing crypto-enabled and reloadable stored-value card solutions, announced today that it has entered into discussions regarding a potential acquisition of OX Agency, a developer of facial recognition and artificial intelligence–based identity verification technology.The proposed transaction aligns with Nexa Cards’ strategy to strengthen its core security, compliance, and identity infrastructure while supporting scalable global growth. OX Agency’s technology is designed to deliver real-time biometric identity verification and AI-driven risk analysis, which would be integrated into Nexa Cards’ onboarding, transaction monitoring, and platform security processes. Management believes the integration of proprietary facial recognition and AI identity technology...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.